METHOD FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE HUMAN COMPLEMENT SYSTEM FOR PREDICTING THE SEVERITY OF THE COURSE OF A SYSTEMIC INFLAMMATORY REACTION Russian patent published in 2021 - IPC G01N33/50 G01N33/53 

Abstract RU 2756764 C1

FIELD: diagnostics.

SUBSTANCE: invention relates to diagnostics, namely to a method for determining the functional activity of the classical pathway of the human complement system for predicting the severity of the course of the systemic inflammatory response. A method for determining the functional activity of the classical pathway of the human complement system for predicting the severity of the course of a systemic inflammatory reaction includes carrying out a lysis reaction of human erythrocytes of group A of the AB0 system (E(A)), sensitized with anti-A monoclonal IgM antibodies (E(A)mAb) and serum under conditions of veronal saline buffer (VBS2+), incubation of the obtained sample, then the reaction of complement-dependent lysis of E(A)mAb is evaluated turbidimetrically, by reducing the optical density of the suspension E(A)mAb at a wavelength of 620 nm determines the degree of erythrocyte lysis in experimental samples according to the calibration graph, where the control E(A)mAb represents 0% lysis, and the control of complete lysis E(A)mAb is 100% lysis, under certain conditions, while the increased functional activity of the classical pathway of the human complement system is noted with a degree of lysis of more than 60%, with a degree lysis from 31% to 59% as normal and with a degree of lysis less than 30% as reduced functional activity of the human complement system.

EFFECT: above-described method allows increasing the accuracy of the method for studying the functional activity of the classical pathway of the complement system, as well as to simplify the registration of the results of the analysis of the functional activity of the classical pathway of the complement system in routine studies and adaptation of the method for screening studies in the conditions of clinical diagnostic laboratories.

1 cl, 5 dwg, 2 tbl, 2 ex

Similar patents RU2756764C1

Title Year Author Number
METHOD FOR DETERMINING COMPLEMENT-ACTIVATING FUNCTION OF SARS-CoV-2 ANTIBODIES FOR PREDICTING SEVERITY OF COVID-19 2023
  • Karganov Mikhail Yurevich
  • Shojbonov Batozhab Batozhargalovich
  • Alchinova Irina Borisovna
  • Pyatskaya Alina Valerevna
  • Radnaeva Chimit Batozhabovna
  • Nikolskaya Olga Sergeevna
  • Pertsov Sergej Sergeevich
  • Morozov Sergej Georgievich
RU2818351C1
METHOD OF PREDICTING SEVERITY OF SYSTEMIC INFLAMMATORY RESPONSE IN HUMAN BODY IN DISEASES 2022
  • Karganov Mikhail Yurevich
  • Shojbonov Batozhab Batozhargalovich
  • Pyatskaya Alina Valerevna
  • Alchinova Irina Borisovna
  • Demorzhi Marina Sergeevna
RU2808416C1
METHOD FOR DETERMINING THE INHIBITORY POTENTIAL OF BLOOD FOR PREDICTING UNCONTROLLED ACTIVATION OF COMPLEMENT SYSTEM IN COVID-19 2023
  • Karganov Mikhail Yurevich
  • Shojbonov Batozhab Batozhargalovich
  • Alchinova Irina Borisovna
  • Nikolskaya Olga Sergeevna
  • Pertsov Sergej Sergeevich
  • Morozov Sergej Georgievich
RU2814496C1
SCREENING TEST FOR DETERMINATION OF THE FUNCTIONAL ACTIVITY OF THE RAT COMPLEMENT SYSTEM 2022
  • Karganov Mikhail Yurevich
  • Shojbonov Batozhab Batozhargalovich
  • Alchinova Irina Borisovna
  • Mavrenkova Polina Vyacheslavovna
  • Demorzhi Marina Sergeevna
  • Tereshkina Natalya Vasilevna
  • Grigoreva Diana Viktorovna
  • Shojbonova Tsypylma Borisovna
  • Tolpygo Svetlana Mikhajlovna
RU2786208C1
SCREENING TEST FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE CLASSIC COMPLEMENT PATHWAY 2018
  • Karganov Mikhail Yurevich
  • Alchinova Irana Borisovna
  • Shojbonov Batozhab Batozhargalovich
  • Grigoreva Diana Viktorovna
  • Tolpygo Svetlana Mikhajlovna
RU2704121C1
METHOD OF DETERMINING THE ACTIVITY OF THE CLASSICAL AND ALTERNATIVE PATHWAYS OF THE MOUSE COMPLEMENT SYSTEM 2022
  • Karganov Mikhail Yurevich
  • Shojbonov Batozhab Batozhargalovich
  • Gruden Marina Alekseevna
  • Alchinova Irina Borisovna
  • Ratmirov Aleksandr Maksimovich
  • Shojbonova Tsypylma Borisovna
  • Demorzhi Marina Sergeevna
  • Grigoreva Diana Viktorovna
  • Litinskaya Olga Anatolevna
  • Lebedeva Olga Alekseevna
  • Dzodzuashvila Liana Rezovna
  • Tolpygo Svetlana Mikhajlovna
RU2800363C1
METHOD FOR DETERMINING THE ACTIVITY OF NEUTRALISING ANTIBODIES AGAINST SARS-CoV-2 IN THE SERUM OR PLASMA OF PEOPLE WITH PAST CASES OF COVID-19 OR VACCINATED WITH PREVENTIVE VACCINES AGAINST THE NOVEL CORONAVIRUS INFECTION COVID-19 USING A SET OF ENZYME IMMUNOASSAY REAGENTS CONTAINING A RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF SURFACE GLYCOPROTEIN S OF CORONAVIRUS SARS-CoV-2 AND RECOMBINANT HUMAN RECEPTOR ACE2 2021
  • Kostin Nikita Nikolaevich
  • Bobik Tatyana Vladimirovna
  • Skryabin Georgij Andreevich
  • Simonova Mariya Aleksandrovna
  • Balmasova Irina Petrovna
  • Abrikosova Viktoriya Aleksandrovna
  • Mokrushina Yuliana Anatolevna
  • Smirnov Ivan Vitalevich
  • Aleshenko Natalya Leonidovna
  • Nikitin Aleksej Eduardovich
  • Chekhonin Vladimir Pavlovich
  • Gabibov Aleksandr Gabibovich
RU2784655C1
PEPTIDE IMMUNOGENS AND A VACCINE COMPOSITION AGAINST CORONAVIRUS INFECTION COVID-19 USING PEPTIDE IMMUNOGENS 2020
  • Ryzhikov Aleksandr Borisovich
  • Ryzhikov Evgenij Aleksandrovich
  • Bogryantseva Marina Polikarpovna
  • Gavrilova Elena Vasilevna
  • Danilenko Elena Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Maksyutov Rinat Amirovich
  • Nechaeva Elena Avgustovna
  • Popova Anna Yurevna
  • Pyankov Oleg Viktorovich
  • Pyankova Olga Grigorevna
  • Susloparov Ivan Mikhajlovich
RU2738081C1
PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS 2020
  • Ryzhikov Aleksandr Borisovich
  • Ryzhikov Evgenij Aleksandrovich
  • Bogryantseva Marina Polikarpovna
  • Gavrilova Elena Vasilevna
  • Danilenko Elena Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Maksyutov Rinat Amirovich
  • Nechaeva Elena Avgustovna
  • Popova Anna Yurevna
  • Pyankov Oleg Viktorovich
  • Pyankova Olga Grigorevna
  • Susloparov Ivan Mikhajlovich
RU2743593C1
PEPTIDE IMMUNOGENS USED AS COMPONENTS OF VACCINE COMPOSITION AGAINST COVID-19 2020
  • Ryzhikov Aleksandr Borisovich
  • Ryzhikov Evgenij Aleksandrovich
  • Bogryantseva Marina Polikarpovna
  • Gavrilova Elena Vasilevna
  • Danilenko Elena Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Maksyutov Rinat Amirovich
  • Nechaeva Elena Avgustovna
  • Popova Anna Yurevna
  • Pyankov Oleg Viktorovich
  • Pyankova Olga Grigorevna
  • Susloparov Ivan Mikhajlovich
RU2743594C1

RU 2 756 764 C1

Authors

Shojbonov Batozhab Batozhargalovich

Drapkina Oksana Mikhajlovna

Baronets Tatyana Pavlovna

Dzodzuashvili Liana Rezovna

Radnaeva Chimit Batozhabovna

Eliashevich Sofya Olegovna

Karganov Mikhail Yurevich

Alchinova Irina Borisovna

Demorzhi Marina Sergeevna

Tereshkina Nataliya Vasilevna

Grigoreva Diana Viktorovna

Kaba Said Ibragimovich

Tolpygo Svetlana Mikhajlovna

Dates

2021-10-05Published

2021-06-09Filed